Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

SSU72 Inhibitors

The chemical class termed SSU72 Inhibitors encompasses a diverse group of compounds, primarily targeting pathways and processes related to RNA polymerase II transcription and pre-mRNA processing. This indirect approach is necessary due to the lack of direct inhibitors for SSU72. The key characteristic of these inhibitors is their ability to influence cellular mechanisms upstream or parallel to SSU72's function. The first group within this class comprises cyclin-dependent kinase (CDK) inhibitors like Flavopiridol Hydrochloride and Roscovitine. These compounds are crucial for their role in regulating transcription, a process closely associated with SSU72's activity. By inhibiting CDKs, these chemicals can potentially alter the phosphorylation state of RNA polymerase II, indirectly affecting SSU72's phosphatase activity. The alteration in the transcriptional landscape can have a downstream impact on SSU72's role in RNA processing. Another significant subset includes compounds like DRB, Triptolide, and α-Amanitin, known for their direct inhibition of RNA polymerase II. By blocking the transcriptional machinery, these inhibitors can indirectly modulate the substrates and functions associated with SSU72.

Additionally, chemicals like Actinomycin D, which intercalates into DNA and inhibits RNA synthesis, also fall under this category, offering a broader mechanism to affect SSU72's functional context. Furthermore, kinase inhibitors like Sorafenib, Sunitinib, Free Base, PD 98059, LY 294002, and Rapamycin, although primarily targeting other pathways like receptor tyrosine kinases, MAPK, PI3K, and mTOR pathways, respectively, can indirectly impact SSU72. These inhibitors affect a wide range of cellular signaling processes, potentially influencing the regulatory networks in which SSU72 operates. In summary, SSU72 inhibitors, though not directly targeting the phosphatase, offer a strategic approach to modulate its activity by influencing related transcriptional and signaling pathways. This approach reflects a growing understanding of the interconnected nature of cellular processes, where altering one component can have cascading effects on related proteins and functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$317.00
(2)

A cyclin-dependent kinase (CDK) inhibitor that can indirectly affect SSU72 by influencing RNA polymerase II transcription.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Another CDK inhibitor, potentially impacting SSU72 activity through transcription regulation.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II transcription, potentially altering SSU72 function.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Known to inhibit transcription, may indirectly affect SSU72-mediated processes.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and inhibits RNA synthesis, indirectly impacting SSU72 functions.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Specifically inhibits RNA polymerase II, which can indirectly influence SSU72 activity.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

While primarily a kinase inhibitor, it might indirectly affect SSU72 through signaling pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

A receptor tyrosine kinase inhibitor that could indirectly impact SSU72 through cellular signaling pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which is part of the MAPK pathway, potentially affecting SSU72 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, could indirectly impact SSU72 through signaling alterations.